| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment | Metabolite | Tissue |
|---|---|---|---|---|---|---|---|
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | 0.056 | ng/mL | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | 0.088 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | AIN-93G (control) | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | 8-oxoRvD1 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|